These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36908258)

  • 21. Legal cannabis market shares during Canada's first year of recreational legalisation.
    Armstrong MJ
    Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socioeconomic factors and substances involved in poisoning-related emergency department visits in British Columbia, Canada.
    Pawer S; Rajabali F; Zheng A; Pike I; Purssell R; Zargaran A; Babul S
    Health Promot Chronic Dis Prev Can; 2021; 41(7-8):211-221. PubMed ID: 34427419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impacts of Canada's cannabis legalization on police-reported crime among youth: early evidence.
    Callaghan RC; Vander Heiden J; Sanches M; Asbridge M; Hathaway A; Kish SJ
    Addiction; 2021 Dec; 116(12):3454-3462. PubMed ID: 34085338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canada's cannabis legalization and police-reported cannabis-related criminal incidents among youth, 2015-2021.
    Callaghan RC; Sanches M; Hathaway A; Asbridge M; MacDonald M; Kish SJ
    Drug Alcohol Depend; 2024 May; 258():109892. PubMed ID: 37183068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearing the air: A study of cannabis-related presentations to urban Alberta emergency departments following legalization.
    Yeung MEM; Weaver CG; Janz K; Haines-Saah R; Lang E
    CJEM; 2020 Nov; 22(6):776-783. PubMed ID: 32616094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency Department Pediatric Visits in Alberta for Cannabis After Legalization.
    Yeung MEM; Weaver CG; Hartmann R; Haines-Saah R; Lang E
    Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34544846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.
    Marquette A; Iraniparast M; Hammond D
    BMJ Open; 2024 Jan; 14(1):e077908. PubMed ID: 38171626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation.
    Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P
    Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute cannabis intoxication in the emergency department: the effect of legalization.
    Baraniecki R; Panchal P; Malhotra DD; Aliferis A; Zia Z
    BMC Emerg Med; 2021 Mar; 21(1):32. PubMed ID: 33731003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.
    Lee C; Round JM; Klarenbach S; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Harm Reduct J; 2021 Jun; 18(1):61. PubMed ID: 34103058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unintentional pediatric poisonings before and during the COVID-19 pandemic: A population-based study.
    Myran DT; Gaudreault A; McCarthy SDS; Pugliese M; Tanuseputro P; Finkelstein Y
    Am J Emerg Med; 2024 Feb; 76():185-192. PubMed ID: 38086185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency department presentations for self-harm among Ontario youth.
    Bethell J; Bondy SJ; Lou WY; Guttmann A; Rhodes AE
    Can J Public Health; 2013 Feb; 104(2):e124-30. PubMed ID: 23618204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019.
    Britch SC; Walsh SL; Vickers-Smith R; Babalonis S; Slavova S
    Subst Use Misuse; 2023; 58(1):66-76. PubMed ID: 36453437
    [No Abstract]   [Full Text] [Related]  

  • 34. Emergency department visits for self-harm in adolescents after release of the Netflix series '13 Reasons Why'.
    Sinyor M; Mallia E; de Oliveira C; Schaffer A; Niederkrotenthaler T; Zaheer J; Mitchell R; Rudoler D; Kurdyak P
    Aust N Z J Psychiatry; 2022 Nov; 56(11):1434-1442. PubMed ID: 34963338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review.
    Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T
    Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis.
    Myran DT; Pugliese M; Roberts RL; Solmi M; Perlman CM; Fiedorowicz J; Tanuseputro P; Anderson KK
    Mol Psychiatry; 2023 Oct; 28(10):4251-4260. PubMed ID: 37500826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada.
    Anderson KK; Rodrigues R; Le B; Mamun M; Archie S; Edwards J; Elton-Marshall T; Gilliland J; Myran DT; Palaniyappan L; Perlman CM; Seabrook JA; Murray RM; Shariff SZ
    Int J Drug Policy; 2024 Jan; 123():104285. PubMed ID: 38071933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada.
    Myran DT; Gaudreault A; Konikoff L; Talarico R; Liccardo Pacula R
    JAMA Netw Open; 2023 Oct; 6(10):e2336113. PubMed ID: 37796504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study.
    Zongo A; Lee C; El-Mourad J; Dyck JRB; Hyshka E; Hanlon JG; Eurich DT
    Can J Psychiatry; 2022 Jul; 67(7):544-552. PubMed ID: 34806435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of marijuana legalization on cannabis-related visits to the emergency department.
    Tolan NV; Terebo T; Chai PR; Erickson TB; Hayes BD; Uljon SN; Petrides AK; Demetriou CA; Melanson SEF
    Clin Toxicol (Phila); 2022 May; 60(5):585-595. PubMed ID: 34935567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.